Skip to main content
Intensive Care Medicine Experimental
Fig. 2 | Intensive Care Medicine Experimental

Fig. 2

From: Therapeutic application of recombinant human ADAMTS-13 improves shock reversal and coagulation status in a trauma hemorrhage and transfusion rat model

Fig. 2

Coagulation parameters. a Clotting time measured in EXTEM array over time. b Maximum clot firmness measured in EXTEM array over time. c Maximum clot firmness of EXTEM and FIBTEM assay subtracted as a reflection of platelet-driven coagulation. d Platelet counts at baseline and exsanguination. e Fibrinogen levels at baseline and exsanguination. ROTEM values presented as mean and standard deviation (SD). Reference values are according to human standards. Platelet count and fibrinogen levels are presented as median and interquartile ranges (IQR). *p < 0.05

Back to article page